JB/CALL/MERCK & CO./110/0.05/21.06.24 Share Price

Warrant

MRYRJB

CH1242788045

Market Closed - Swiss Exchange 08:50:00 26/04/2024 pm IST
1.01 CHF +9.78% Intraday chart for JB/CALL/MERCK & CO./110/0.05/21.06.24
1 month+26.25%
3 months+62.90%

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Bank Julius Bär
MRYRJB
ISINCH1242788045
Date issued 30/01/2023
Strike 110 $
Maturity 21/06/2024 (33 Days)
Parity 20 : 1
Emission price 0.5 CHF
Emission volume N/A
Settlement Barausgleich
Currency CHF

Technical Indicators

Highest since issue 1.05 CHF
Lowest since issue 0.15 CHF

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2 USD
Average target price
141.6 USD
Spread / Average Target
+7.96%
Consensus
  1. Stock Market
  2. Warrants
  3. MRYRJB Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW